Senna-S - 0182-1113-10 - (Docusate sodium and Sennosides)

Alphabetical Index


Drug Information of Senna-S

Product NDC: 0182-1113
Proprietary Name: Senna-S
Non Proprietary Name: Docusate sodium and Sennosides
Active Ingredient(s): 50; 8.6    mg/1; mg/1 & nbsp;   Docusate sodium and Sennosides
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Senna-S

Product NDC: 0182-1113
Labeler Name: Goldline Laboratories, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part334
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 19990323

Package Information of Senna-S

Package NDC: 0182-1113-10
Package Description: 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0182-1113-10)

NDC Information of Senna-S

NDC Code 0182-1113-10
Proprietary Name Senna-S
Package Description 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0182-1113-10)
Product NDC 0182-1113
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Docusate sodium and Sennosides
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 19990323
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Goldline Laboratories, Inc.
Substance Name DOCUSATE SODIUM; SENNOSIDES
Strength Number 50; 8.6
Strength Unit mg/1; mg/1
Pharmaceutical Classes

Complete Information of Senna-S


General Information